Navigation

Investiment.io
Financial analysis platform

AbbVie Inc.

ABBV โ€ข NYSE

$294.55
โ–ผ0.48 (0.16%)โ€ข REGULAR

AbbVie Inc.

$294.55
โ–ผ0.2%
๐Ÿ“ŠSummary๐Ÿ“‹SEC Filings๐Ÿ‘ฅInsider Trading

๐Ÿ“ˆ Advanced DCF Valuation

Professional-grade discounted cash flow analysis with scenario modeling for ABBV

Healthcare โ€ข Drug Manufacturers - General โ€ข Market Cap: $520,651,382,932.30

Scenario Analysis

Compare different scenarios to understand valuation sensitivity

๐Ÿ”ป-82.6% upside

Conservative Case

$51.32

๐Ÿ“Š-74.1% upside

Base Case

$76.38

๐Ÿ”บ-65.1% upside

Optimistic Case

$102.81

๐Ÿ’ฐMarket Price

Current Price

$294.55

DCF Model & Results

Detailed cash flow projections and valuation analysis

๐Ÿ’ต Enhanced Cash Flow Projections

YearRevenueGrowth %Operating Margin %NOPATCapExFCFPV of FCF
1$64,218,000,000.005.0%24.6%$12,504,712,500.00$1,316,469,000.00$13,099,493,500.00$11,989,042,396.89
2$66,786,720,000.004.0%24.6%$13,004,901,000.00$1,294,326,633.60$13,701,332,366.40$11,476,852,129.26
3$69,124,255,200.003.5%24.6%$13,460,072,535.00$1,269,527,430.47$14,252,585,084.53$10,926,564,132.92
4$71,197,982,856.003.0%24.6%$13,863,874,711.05$1,239,180,422.19$14,750,265,136.26$10,349,510,177.58
5$72,977,932,427.402.5%24.6%$14,210,471,578.83$1,203,679,887.00$15,187,229,916.79$9,752,782,278.25
Terminalโ€”3.0%โ€”โ€”โ€”$221,728,397,313.93$142,387,308,005.18
Enterprise Value$196,882,059,120.08
Net Debt$61,773,000,000.00
Equity Value$135,109,059,120.08
Price per Share$76.38
EV/Revenue (Final Year)2.7x
Terminal Value %72.3%
WACC9.3%

๐Ÿฅ Company Financial Health

Historical Revenue Growth2.3%
Current Operating Margin24.6%
FCF Conversion Rate29.1%
Net Debt/Equity0.00
ROE0.0%
ROIC0.0%
Beta1.20
Interest Coverage0.00
Enhanced DCF data sourced from Financial Modeling Prep (FMP) โ€ข Model incorporates industry best practices and academic research โ€ข Calculations are estimates and should not be used as sole investment advice โ€ข Consult with a financial advisor before making investment decisions